Terms: = Lymphoma AND PAX5, Q02548, 5079, ENSG00000196092, BSAP
735 results:
1. The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemia.
Li X; Huang Z; Zhu L; Lai W; Li Y; Chen H; Liu D; Huang J; Zhou D; Li Y; Weng W; Xu H; Xu L; Luo Z; Fang J
BMC Med Genomics; 2024 May; 17(1):149. PubMed ID: 38811988
[TBL] [Abstract] [Full Text] [Related]
2. A multiomic characterization of the leukemia cell line REH using short- and long-read sequencing.
Lysenkova Wiklander M; Arvidsson G; Bunikis I; Lundmark A; Raine A; Marincevic-Zuniga Y; Gezelius H; Bremer A; Feuk L; Ameur A; Nordlund J
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38777370
[TBL] [Abstract] [Full Text] [Related]
3. Primary cutaneous anaplastic large-cell lymphoma resembling infratemporal space infection: a case report.
Yan X; Ren W; Li S; Zhu Z; Gao L; Zhi K
BMC Oral Health; 2024 Apr; 24(1):470. PubMed ID: 38637781
[TBL] [Abstract] [Full Text] [Related]
4. ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression.
Baker J; Zadeh SL; Aguilera NS
J Hematop; 2024 Jun; 17(2):109-114. PubMed ID: 38573563
[TBL] [Abstract] [Full Text] [Related]
5. Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell lymphoma: Immunohistochemical Analysis of 152 Pathology Specimens From 88 Patients.
Saka M; Fujimoto M; Mizoguchi K; Tsujimura M; Saeki M; Hirata M; Shibuya S; Odani K; Sakurai T; Yuba Y; Moriyoshi K; Nakajima N; Sumiyoshi S; Kono F; Ono K; Shirase T; Watanabe C; Yoshizawa A; Haga H
Am J Surg Pathol; 2024 Jun; 48(6):671-680. PubMed ID: 38497417
[TBL] [Abstract] [Full Text] [Related]
6. Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining IKZF1
Liu HC; Huang YJ; Jaing TH; Wu KH; Chen SH; Wang SC; Yeh TC; Hsiao CC; Chang TK; Yen HJ; Huang FL; Lin PC; Hou JY; Sheen JM; Liao YM; Chang TY; Chen YC; Chiou SS; Yang CP; Pui CH; Liang DC; Shih LY
Br J Haematol; 2024 Apr; 204(4):1344-1353. PubMed ID: 38479427
[TBL] [Abstract] [Full Text] [Related]
7. Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain.
van Outersterp I; Tasian SK; Reichert CEJ; Boeree A; de Groot-Kruseman HA; Escherich G; Boer JM; den Boer ML
Blood; 2024 May; 143(21):2178-2189. PubMed ID: 38394665
[TBL] [Abstract] [Full Text] [Related]
8. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
[TBL] [Abstract] [Full Text] [Related]
9. The prognostic significance of programmed cell death protein 1 and its ligand on lymphoma cells and tumor-immune cells in diffuse large B-cell lymphoma, not otherwise specified.
Slak TC; Miceska S; Gasljevic G; Boltezar L; Kloboves-Prevodnik V
Radiol Oncol; 2024 Mar; 58(1):99-109. PubMed ID: 38378036
[TBL] [Abstract] [Full Text] [Related]
10. Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms.
Kemps PG; Kester L; Scheijde-Vermeulen MA; van Noesel CJM; Verdijk RM; Diepstra A; van Marion AMW; Dors N; van den Bos C; Bruggink AH; Hogendoorn PCW; van Halteren AGS
Histopathology; 2024 Apr; 84(5):837-846. PubMed ID: 38213281
[TBL] [Abstract] [Full Text] [Related]
11. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
13. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse.
Yan X; Chen B; Jing H; Yang Z; Zhang T; Lin Y; Shi J
J Hematop; 2023 Dec; 16(4):235-240. PubMed ID: 38175437
[TBL] [Abstract] [Full Text] [Related]
14. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Bastian L; Beder T; Barz MJ; Bendig S; Bartsch L; Walter W; Wolgast N; Brändl B; Rohrandt C; Hansen BT; Hartmann AM; Iben K; Das Gupta D; Denker M; Zimmermann J; Wittig M; Chitadze G; Neumann M; Schneller F; Fiedler W; Steffen B; Stelljes M; Faul C; Schwartz S; Müller FJ; Cario G; Harder L; Haferlach C; Pfeifer H; Gökbuget N; Brüggemann M; Baldus CD
Blood; 2024 Apr; 143(14):1391-1398. PubMed ID: 38153913
[TBL] [Abstract] [Full Text] [Related]
15. Primary cardiac large B cell lymphoma.
Arun Kumar S; Mishra R; Malempati SC; Bindal P
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38151268
[TBL] [Abstract] [Full Text] [Related]
16. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
17. Hysterectomy, oophorectomy and risk of non-Hodgkin's lymphoma.
Luo J; Hendryx M; Rohan TE; Saquib N; Shadyab AH; Su L; Hosgood D; Schnatz PF; Qi L; Anderson GL
Int J Cancer; 2024 Apr; 154(8):1433-1442. PubMed ID: 38112671
[TBL] [Abstract] [Full Text] [Related]
18. Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression.
Leeman-Neill RJ; Song D; Bizarro J; Wacheul L; Rothschild G; Singh S; Yang Y; Sarode AY; Gollapalli K; Wu L; Zhang W; Chen Y; Lauring MC; Whisenant DE; Bhavsar S; Lim J; Swerdlow SH; Bhagat G; Zhao Q; Berchowitz LE; Lafontaine DLJ; Wang J; Basu U
Nat Genet; 2023 Dec; 55(12):2160-2174. PubMed ID: 38049665
[TBL] [Abstract] [Full Text] [Related]
19. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
[TBL] [Abstract] [Full Text] [Related]
20. Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.
Fregona V; Bayet M; Bouttier M; Largeaud L; Hamelle C; Jamrog LA; Prade N; Lagarde S; Hebrard S; Luquet I; Mansat-De Mas V; Nolla M; Pasquet M; Didier C; Khamlichi AA; Broccardo C; Delabesse É; Mancini SJC; Gerby B
J Exp Med; 2024 Jan; 221(1):. PubMed ID: 37930337
[TBL] [Abstract] [Full Text] [Related]
[Next]
